Cryo-EM Captures CRISPR-Cas9 Base Editor in Action
Researchers have obtained the first 3D structure of CRISPR-Cas9 base editor which may lead to more versatility and control for use in patients.
Researchers have obtained the first 3D structure of CRISPR-Cas9 base editor which may lead to more versatility and control for use in patients.
The mini colons replicate both the physical structure and cellular diversity in the colon in both healthy and diseased states.
Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver.
Workflow design and data management are pivotal components of cell and gene therapy research and development. Advances in artificial intelligence, informatics, and automation have made…
ASO-therapy rescues defects in preclinical Timothy syndrome models, a neurodevelopmental disorder with significant morbidity and mortality.
Possibilities include the classification of malignancies, the development of anti-obesity drugs, and the reprogramming of cells to reverse age-related diseases.
Artificial cells built with dynamically reconfigurable peptide-DNA cytoskeletons demonstrate tunable functionality.
Defense cells are constantly stimulated by healthy tissue to keep them vigilant and ready to respond to pathogens.
Senescent cells displayed more proinflammatory, metabolically deregulated, and pathology-associated signatures
Defense cells are constantly stimulated by healthy tissue to keep them vigilant and ready to respond to pathogens.
Gene therapy has undergone a renaissance in recent years, with several drugs offering beneficial, even life-saving treatments, now approved by the FDA. One example was…